Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like they may need to put some clothes on. LOL Closed up 10% or so.
Up! Very large transactions. eom
Diamond hands here as well!
$SAGA board has fixed the close of business on October 17, 2023, as the "Record Date" for determing stockholders entitled to receive notice of and vote at the special meeting.
🗳 VOTING 🗳$SAGA board has fixed the close of business on October 17, 2023, as the "Record Date" for determing stockholders entitled to receive notice of and vote at the special meeting.
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) October 16, 2023
⚠️ Tomorrow $ENZC pic.twitter.com/tcJkeYHxbd
We knew about Clone-3 for #HIV, but now for the 1st🥇time, we’re hearing about ??????????-?? for HIV, and ??????????-?????? ?????? ??????????-?????? for #SARSCoV2 🤯🤯🤯
#BGEN #ENZC 🔥🔥🔥
— 𝓓𝓮𝓶𝓲 ᥫ᭡ (@Demi6851) September 29, 2023
We knew about Clone-3 for #HIV, but now for the 1st🥇time, we’re hearing about 𝗖𝗹𝗼𝗻𝗲-𝟳 for HIV, and 𝗛𝘂𝗺𝗮𝗻-𝟭𝟵𝗚 𝗮𝗻𝗱 𝗛𝘂𝗺𝗮𝗻-𝟭𝟵𝗔 for #SARSCoV2 🤯🤯🤯
HIV
“Biogenysis is pursuing a comprehensive solution for both preventing and curing… pic.twitter.com/84enwy8HuZ
Yes, I've been going through the new website. It does look impressive!
We are launching the website http://biogenysis.com #BGEN #ENZC
https://twitter.com/drgauravchandra/status/1707744981400621452
For those ripping on Barry at $SAGA, you have no clue how this works. He is like the executor of the SPAC. Once de-SPAC occurs, the new executive team comes in. Per Exhibit 6:
✅
@drgauravchandra
will be CEO
✅ C. Cotropia will be COO
✅ J. Cotropia and Harry will be CSO.
For those ripping on Barry at $SAGA, you have no clue how this works. He is like the executor of the SPAC. Once de-SPAC occurs, the new executive team comes in. Per Exhibit 6:
— Zach (@CryptoGodDude) September 22, 2023
✅ @drgauravchandra will be CEO
✅ C. Cotropia will be COO
✅ J. Cotropia and Harry will be CSO.$ENZC pic.twitter.com/5A3Y8zj57P
Dr. Chandra Tweet: #BGEN continues to make a significant impact in drug discovery and development by utilizing advanced AI technology. Our focus is on safeguarding our assets while expanding our IP portfolio to include #AI -driven monoclonal antibodies. With these antibodies, we aim to revolutionize the fight against #HIV , #COVID19 mutations, and other viruses. Collaborating with pharmaceutical companies, our focus is to cover all viruses in our repository, providing patients with necessary diagnostics and therapies. Our "AI Platform is constantly evolving with disruptive innovations" in healthcare. We are proud to be at the forefront of this crucial work and look forward to continuing to positively impact the world. #ENZC #NASDAQ https://nasdaq.com/press-release/enzolytics-announces-the-signing-of-the-business-combination-agreement-with-sagaliam
Last edited
4:37 PM · Sep 18, 2023
·
3,407
Views
#BGEN continues to make a significant impact in drug discovery and development by utilizing advanced AI technology. Our focus is on safeguarding our assets while expanding our IP portfolio to include #AI -driven monoclonal antibodies. With these antibodies, we aim to…
— Gaurav Chandra M.D. (@drgauravchandra) September 18, 2023
Looking forward to Monday! eom
NASDAQ trending on Twitter with ENZC all over it! Great day to be an ENZC investor!
Yes indeed God_Father! Onward and upward! eom
Yes indeed God_Father! Onward and upward! eom
Good job! eom
Yes indeed! ENZC is trending on Twitter! eom
DEAL COMPLETE
$ENZC 🏆DEAL COMPLETE 🏆
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) September 15, 2023
𝙎𝘼𝙂𝘼𝙇𝙄𝘼𝙈 𝘼𝘾𝙌𝙐𝙄𝙎𝙄𝙏𝙄𝙊𝙉 𝘾𝙊𝙍𝙋. 𝘼𝙉𝙉𝙊𝙐𝙉𝘾𝙀𝙎 𝙀𝙓𝙀𝘾𝙐𝙏𝙄𝙊𝙉 𝙊𝙁 𝘿𝙀𝙁𝙄𝙉𝙄𝙏𝙄𝙑𝙀 𝘽𝙐𝙎𝙄𝙉𝙀𝙎𝙎 𝘾𝙊𝙈𝘽𝙄𝙉𝘼𝙏𝙄𝙊𝙉 𝘼𝙂𝙍𝙀𝙀𝙈𝙀𝙉𝙏💥💥💥
The Company has executed a binding business combination agreement for the… https://t.co/B463BzAHUo pic.twitter.com/l8DafPxow5
"Resistance is greatest just before the finish line."
— Gaurav Chandra M.D. (@drgauravchandra) September 12, 2023
Steven Pressfield
From Dr. Chandra: "Resistance is greatest just before the finish line."
Steven Pressfield
1:00 PM · Sep 12, 2023
"Resistance is greatest just before the finish line."
— Gaurav Chandra M.D. (@drgauravchandra) September 12, 2023
Steven Pressfield
Better communications coming: "The Biogenysis website will have a lot more details. Potential partners and shareholders will be able to communicate via email listed on the website.We intend to have a monthly blog posts and communications via the corporate website. Watch for the website http://biogenysis.com"
3:26 PM · Sep 5, 2023
·
The Biogenysis website will have a lot more details. Potential partners and shareholders will be able to communicate via email listed on the website.We intend to have a monthly blog posts and communications via the corporate website. Watch for the website https://t.co/U7cTcPLOJI
— Gaurav Chandra M.D. (@drgauravchandra) September 5, 2023
It's not ready as yet.We will notify once the website is launched.
— Gaurav Chandra M.D. (@drgauravchandra) September 5, 2023
Statement from today's news: Many more developments are planned including the patenting of each. Our partnering with Khalpey AI Lab and Contenta, Ltd. will accelerate the Company's objective to use AI to develop infectious disease therapeutics for improving health care around the world. This partnership and our planned business combination with Sagaliam Acquisition Corporation will provide the basis for achieving this objective."
News! Biogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.
https://www.otcmarkets.com/stock/ENZC/news/Biogenysis-Inc-Announces-Partnering-with-Khalpey-AI-Lab-and-Contenta-Ltd-to-Incorporate-AI-in-Microbiome-Analysis-to-Ide?id=412970
Gaurav Chandra M.D.
@drgauravchandra
Acknowledgment from our shareholders is genuinely appreciated. It is an excellent source of motivation for us as a team to keep pushing ourselves towards excellence. #BGEN #ENZCstrong
2:05 PM · Aug 25, 2023
·
Acknowledgment from our shareholders is genuinely appreciated. It is an excellent source of motivation for us as a team to keep pushing ourselves towards excellence. #BGEN #ENZCstrong
— Gaurav Chandra M.D. (@drgauravchandra) August 25, 2023
Your post=Big $$$$ eom.
"This pretty much says it all: Dr. Chandra, “The Company aims to collaborate, license, or partner with pharma entities for 19 viruses in our repetoire for diagnostics, therapeutics, and vaccines.” GLTA!"
Absolutely!
#BGEN has a well-defined IP portfolio aligned with a licensing strategy. Our #monoclonalantibodies, both IgG and IgA, being universal, broadly neutralizing, durable, and unaffected by mutations, are critical solutions for COVID-19 mutations. The Company aims to collaborate, license, or partner with pharma entities for 19 viruses in our repetoire for diagnostics, therapeutics, and vaccines. #SAGA #SPAC will make this possible.
@BiogenysisInc
https://accesswire.com/776544/Biogenysis-International-Patent-Application-Covering-Its-Anti-SARS-CoV-2-Monoclonal-Antibodies-Advances-to-Prosecution-in-Europe-and-as-a-US-National-Stage-Application
#SARSCOV2 #nasal #patent #AI #PCT #sciencealwayswins
#BGEN has a well-defined IP portfolio aligned with a licensing strategy. Our #monoclonalantibodies, both IgG and IgA, being universal, broadly neutralizing, durable, and unaffected by mutations, are critical solutions for COVID-19 mutations. The Company aims to collaborate,…
— Gaurav Chandra M.D. (@drgauravchandra) August 24, 2023
Financial Statement Filing Published!
$ENZC Financial Statement Filing Published! https://t.co/wDjNtj1Jm7 pic.twitter.com/LD8RVYbqbt
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) August 22, 2023
Extra green! eom
Green! For now eom
$ENZC 💭Perspectives 💭
$ENZC 💭Perspectives 💭
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) August 17, 2023
The company has been very explicit about where they stand with the business combination agreement with $SAGA. They said they would be providing guidance to us later this month. So in the next 2 weeks we'll know a lot more. Also, we know the deal has to be… https://t.co/7aUvpCKJvA pic.twitter.com/IkxDqGE2fZ
Per SEC Form 13F-HR (Institutional Investments), ATW SPAC MANAGEMENT LLC purchased ??????,?????? Right Class Shares of $SAGA in Q2–🍾??????????????? the $450MM #SPAC deal w/ $ENZC was announced🍾
#ENZC 🔥
— 𝓓𝓮𝓶𝓲 ᥫ᭡ (@Demi6851) August 15, 2023
Per SEC Form 13F-HR (Institutional Investments), ATW SPAC MANAGEMENT LLC purchased 𝟗𝟗𝟎,𝟎𝟎𝟎 Right Class Shares of $SAGA in Q2–🍾𝐀̳𝐅̳𝐓̳𝐄̳𝐑̳ the $450MM #SPAC deal w/ $ENZC was announced🍾
🔥They also hold 120,000 Class A Common shares —>valued @ $1,344,000🔥 https://t.co/BK90F4YdWY pic.twitter.com/Q6fARFFzL1
$ENZC What does a Hedge Fund that's received multiple "Top Performing" Awards, and holds $8.4 Billion of discretionary assets want to do with $SAGA? I guess we'll soon find out 😉
$ENZC What does a Hedge Fund that's received multiple "Top Performing" Awards, and holds $8.4 Billion of discretionary assets want to do with $SAGA? I guess we'll soon find out 😉#Winning2023 🏆 https://t.co/2G1NYzqQ1q pic.twitter.com/JPXoO2mK06
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) August 7, 2023
"Finally, ENZC has negotiated additional compensation in the form of a monthly management fee to be paid by Sagaliam Acquisition Corp (SAGA) to ENZC over a 30-month period following the close of the purchase of BGEN and VIRO. The funds will be used to facilitate the continued compliance of ENZC's OTC Market filing requirements, administration of the dividend payment of the 45 million SAGA share issuance received as part of the SAGA purchase transaction to the ENZC shareholders and the Company's development of a new business strategy to be implemented after the close of the sale of BGEN and VIRO. ENZC and SAGA have continued the process of documenting the Business Combination agreement and expect to provide further guidance later this month."
https://www.accesswire.com/772346/Virogentics-Inc-Provides-Update-on-African-Project-European-Medicine-Agency-Application-and-Clinical-Trials-for-Application-for-Type-2-Diabetes
I get pertinent info on ENZC, on Twitter, well before I see it here!
My pleasure! eom.
Awesome Godfather post on Twitter:
$ENZC 💥 CATALYSTS 💥
— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) July 29, 2023
1️⃣ $450MM business combination agreement with $SAGA to finalize "as soon as possible". My expectation: August 🔥🔥🔥🔥
2️⃣ Filing Super 8-K with #SAGA when the transaction closes. My expectation: ~October
3️⃣ Share dividend paid to #ENZC shareholders 6… https://t.co/oSZrmV5FZT
CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC
Monday, July 24, 2023 2:00 PM
https://www.accesswire.com/769929/CORRECTION-FROM-SOURCE-Virogentics-Announces-Approval-of-Final-Protocol-from-the-Dept-for-HIV-and-AIDS-Ministry-of-Health-of-the-DRC
Barry Kostiner, CEO of Sagaliam, commented, "I continue to be impressed by the progress of Mr. Zhabiov and his team. The need in Africa for low-cost solutions to the AIDS epidemic is great. Virogentics promises to deliver a high efficacy, economic solution. The heavy lifting has already been completed, with the science well understood, and strong expectations for success in the African patient trials. Our African partners, both government leadership and healthcare institutions, understand the importance of ITV-1 and have facilitated accelerated regulatory approval and the launch of clinical trials. The hurdle to bringing the Virogentics solutions to wide adoption is funding. I am grateful that we have the opportunity to use the Sagaliam Nasdaq platform to facilitate the raising of capital to accelerate the administration of Virogentics technology in Africa and globally."
https://www.accesswire.com/769863/Virogentics-Inc-to-Introduce-a-Dietary-Supplement-Offers-Additional-Information-on-ITV-1-and-Diabetic-Clinical-Trials
Good info. eom